Antibiotics Medicines

Serotonin-Dopamine Antagonists in the Treatment of Stuttering

by Nathan Lavid
from California, USA

The aim of this article is to discuss the use of the serotonin-dopamine antagonists (SDAs) in those who stutter. 

Stuttering, like nausea, schizophrenia, and Tourette syndrome, is associated with increased activity of the neurotransmitter dopamine.   Neuroimaging and pharmacological research has revealed that, in part, hyperactivity of the dopaminergic system exacerbates or induces stuttering speech.

Read «Serotonin-Dopamine Antagonists in the Treatment of Stuttering»

Search